病院・検査機器の世界市場-2024～2031年

概要

病院・検査機器の世界市場は、2023年に419億2,000万米ドルに達し、2031年には777億3,000万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは8.0%で成長すると予測されています。

病院・検査機器は、ヘルスケアや研究で医療状態の診断、治療、調査に使用される多様なツールやシステムです。これには、MRIやCTスキャナのような高度な画像診断装置、患者モニタリングシステム、手術器具、検査分析装置、滅菌装置などが含まれます。これらの機器は、安全性と品質基準を満たしながら、正確な診断、効果的な治療、医学研究の進歩を保証します。

市場力学：

促進要因と阻害要因

ヘルスケアインフラへの投資拡大

世界の病院・検査機器市場は、新興国を中心に世界的にヘルスケアインフラへの投資が増加していることが牽引しています。政府や民間団体は、高度な診断・治療技術の需要を満たすため、施設の近代化に投資しています。この動向は、患者ケアの強化、診断ミスの削減、医療処置の効率化を目的としています。自動化、ロボット工学、AIを搭載した診断ツールのような革新的な技術の採用も、ヘルスケアプロバイダーがより迅速で正確な結果を提供しようと努めていることから、市場を牽引しています。

例えば、2024年11月、JPナッダ化学肥料大臣は、インドの医療機器産業を強化するため、500ルピーのスキームを立ち上げました。この計画は、主要部品と付属品の製造、技能開発、臨床試験支援、共通インフラ開発、産業振興に重点を置くことを目的としています。当初の支出は27年度までの3年間です。このスキームは、医療機器クラスターのための共通施設、能力開発と技能開発、輸入依存度を下げるための限界投資スキーム、臨床研究支援、医療機器振興スキームの5つの要素から構成されています。研究開発ラボや試験施設を含むインフラ整備には1億1000万ルピーが割り当てられました。

さらに、2024年9月、バートラム・キャピタルは、ツーソンに拠点を置く先端材料、実験機器、実験用品、分析サービスのサプライヤーであるMSE Supplies, LLCに投資しました。MSEは100カ国以上の科学者やエンジニアを10,000以上の製品でサポートしています。今回の投資は、バートラムにとって2番目のプラットフォームであり、中堅以下の企業を対象とした初のビジネスサービス部門への投資です。取引条件は公表されていないです。

厳しい規制要件

世界の病院・検査機器市場は、FDA、EMA、ISOなどの機関が定める厳しい規制やコンプライアンス要件により、大きな課題に直面しています。これらの基準は、医療機器や検査機器の安全性、有効性、品質を保証するものです。これらの基準を満たすためには、大規模な試験、臨床試験、包括的な文書化が必要となり、承認までの期間が長くなり、新技術が遅れる可能性があります。製造業者、特に中小企業（SME）は、資金と技術的リソースの不足のため、こうした規制の枠組みを乗り切るのに苦労しています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • ヘルスケアインフラへの投資増加
• 抑制要因
  • 厳格な規制要件
• 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 病院設備
• 実験装置

第7章 技術別

• 自動化装置
• 手動装置
• 半自動システム

第8章 エンドユーザー別

• 病院
• 診断検査室
• 学術研究機関
• 専門クリニック

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Medtronic Plc
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• GE Healthcare
• Philips Healthcare
• Siemens Healthineers
• Stryker Corporation
• Hill-Rom Holdings, Inc.
• Thermo Fisher Scientific
• Agilent Technologies
• PerkinElmer, Inc
• Roche Diagnostics（LIST NOT EXHAUSTIVE）

第12章 付録

Overview

The global hospital and laboratory equipment market reached US$ 41.92 billion in 2023 and is expected to reach US$ 77.73 billion by 2031, growing at a CAGR of 8.0% during the forecast period 2024-2031.

Hospital and laboratory equipment is a diverse array of tools and systems used in healthcare and research to diagnose, treat, and study medical conditions. It includes advanced imaging devices like MRI and CT scanners, patient monitoring systems, surgical instruments, laboratory analyzers, and sterilization units. These tools ensure accurate diagnostics, effective treatments, and advancements in medical research, while meeting safety and quality standards.

Market Dynamics: Drivers & Restraints

Growing Investments in Healthcare Infrastructure

The global hospital and laboratory equipment market is driven by the increasing investment in healthcare infrastructure worldwide, particularly in emerging economies. Governments and private organizations are investing in modernizing facilities to meet the demand for advanced diagnostic and therapeutic technologies. This trend aims to enhance patient care, reduce diagnostic errors, and improve medical procedures efficiency. The adoption of innovative technologies like automation, robotics, and AI-powered diagnostic tools is also driving the market, as healthcare providers strive to deliver faster and more accurate results.

For instance, in November 2024, Union Chemicals and Fertilisers Minister JP Nadda has launched a Rs 500 crore scheme to strengthen India's medical devices industry. The scheme aims to focus on manufacturing key components and accessories, skill development, clinical studies support, common infrastructure development, and industry promotion. The initial outlay will last for three years, up to FY27. The scheme consists of five components: common facilities for medical device clusters, capacity building and skill development, a marginal investment scheme to reduce import dependence, clinical studies support, and a medical device promotion scheme. Rs 110 crore has been allocated for infrastructure development, including R&D labs and testing facilities.

Moreover, in September 2024, Bertram Capital has invested in MSE Supplies, LLC, a Tucson-based supplier of advanced materials, laboratory equipment, lab supplies, and analytical services. MSE supports scientists and engineers in over 100 countries with over 10,000 products. The investment is Bertram's second platform and first Business Services sector investment in lower middle market businesses. The terms of the transaction were not disclosed.

Stringent Regulatory Requirements

The global hospital and laboratory equipment market faces significant challenges due to stringent regulatory and compliance requirements set by bodies like the FDA, EMA, and ISO. These standards ensure safety, efficacy, and quality of medical and laboratory equipment. Meeting these standards requires extensive testing, clinical trials, and comprehensive documentation, leading to lengthy approval timelines and potential delays in new technologies. Manufacturers, particularly small and medium-sized enterprises (SMEs), struggle to navigate these regulatory frameworks due to lack of financial and technical resources.

Segment Analysis

The global hospital and laboratory equipment market is segmented based on product type, technology, end user and region.

Product type:

Hospital equipment segment is expected to dominate the hospital and laboratory equipment market share

The hospital equipment segment holds a major portion of the hospital and laboratory equipment market share and is expected to continue to hold a significant portion of the hospital and laboratory equipment market share during the forecast period.

Surgical instruments are essential tools for various medical procedures, including routine surgeries and complex interventions. They ensure precision, efficiency, and safety. The increasing prevalence of chronic diseases and the number of surgical procedures worldwide have driven the demand for high-quality, specialized instruments. Technological advancements, such as titanium and stainless steel integration, have improved the durability, sterility, and ergonomics of these instruments. Disposable surgical instruments have also addressed concerns about cross-contamination and infection control. The focus on improving surgical outcomes and reducing patient recovery times has further highlighted the importance of surgical instruments in the hospital and laboratory equipment market.

Laboratory Equipment:

Laboratory equipment segment is the fastest-growing segment in hospital and laboratory equipment market share

The laboratory equipment segment is the fastest-growing segment in the hospital and laboratory equipment market share and is expected to hold the market share over the forecast period.

Analytical instruments are crucial in the global hospital and laboratory equipment market, driving advancements in diagnostics, research, and quality control. They analyze biological samples, detect diseases, and monitor patient health. In hospitals, they guide treatment decisions through precise measurements of biochemical markers and blood gases. In laboratories, they facilitate research in genomics, proteomics, and drug development, fostering personalized medicine innovation. Technological innovations like automation and artificial intelligence have enhanced the speed, accuracy, and efficiency of analytical instruments, making them indispensable in modern healthcare and research settings. They also play a significant role in quality control in pharmaceutical manufacturing, ensuring regulatory compliance.

Geographical Analysis

North America is expected to hold a significant position in the hospital and laboratory equipment market share

North America holds a substantial position in the hospital and laboratory equipment market and is expected to hold most of the market share.

North America dominates the global hospital and laboratory equipment market due to advanced healthcare infrastructure, high healthcare expenditure, and strong technological adoption. Major medical device manufacturers, robust research funding, and high prevalence of chronic diseases contribute to its dominance. The demand for minimally invasive surgeries and precision diagnostics, coupled with favorable reimbursement policies, accelerates market growth. Government initiatives like the NIH and the growing focus on digital health technologies like AI-driven diagnostics and telemedicine further support the development and adoption of cutting-edge hospital and laboratory equipment.

For instance, in June 2024, Sky Medical Supplies has introduced a new line of affordable medical equipment, including manual and power wheelchairs, mobility scooters, hospital beds, oxygen concentrators, and lift chairs. The company's co-founder, Semaynesh Miftah, aims to provide reliable and affordable medical tools for a better quality of life. Sky Medical Supplies, founded in May 2021, also offers incontinence products, ADLs, and orthotics. The company's mission is to ensure everyone has access to necessary tools for a better quality of life.

Moreover, in September 2024, Thermo Fisher Scientific has launched Thermo Scientific Connect Edge, an enhanced hardware for the InstrumentConnect 24/7 laboratory equipment remote monitoring platform. Connect Edge is an Open Protocol Communication Unified Architecture server that allows users to send vital data to cloud or premise-based systems, including LIMS or BMS. It allows monitoring of 10 or more laboratory devices from a single gateway using Ethernet or Wi-Fi.

Asia-Pacific is growing at the fastest pace in the hospital and laboratory equipment market

Asia-Pacific holds the fastest pace in the hospital and laboratory equipment market and is expected to hold most of the market share due to economic development, healthcare infrastructure expansion, and investments. The growing population and prevalence of chronic and infectious diseases drive demand for advanced diagnostic and therapeutic equipment.

Moreover, Government initiatives in countries like China and India are promoting local manufacturing of medical devices, while advanced technologies like automated laboratory systems and precision medicine are gaining traction. The region's focus on medical tourism, particularly in cost-effective and high-quality countries, also drives demand for sophisticated hospital and laboratory equipment.

For instance, in January 2024, FUST Lab is a technology startup focusing on uniform nanoscale dispersion/emulsification technologies without surfactants, using ultrasonic technology and a spin-off from the Korea Research Institute of Standards and Science.

Competitive Landscape

The major global players in the hospital and laboratory equipment market include Medtronic, GE Healthcare, Philips Healthcare, Siemens Healthineers, Stryker Corporation, Hill-Rom Holdings, Inc., Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Inc, Roche Diagnostics among others.

Emerging Players

The emerging players in the hospital and laboratory equipment market include Biomerieux, Veeco Instruments, Molecular Devices and among others.

Key Developments

• In August 2024, Metropolis Healthcare Limited has launched two advanced diagnostic laboratories in Telangana, Warangal and Nizamabad, as part of its strategic plan to improve diagnostic services in Tier 2 and Tier 3 cities. The facilities, covering 1,200 sq. ft., can process over 15,000 samples per month and offer a range of tests from basic pathology to advanced molecular diagnostics. By integrating state-of-the-art technology, Metropolis aims to strengthen local healthcare infrastructure and increase access to high-quality diagnostics for residents in these regions.
• In October 2024, The Saudi Food and Drug Authority (SFDA) has launched an initiative to develop diagnostic laboratory equipment and advance 3D printing in hospitals. The initiative aims to foster innovation, research, and development while reducing costs for hospitals and medical laboratories. The equipment and reagents are provided for diagnostic and therapeutic use within hospitals and are not intended for commercial purposes. The initiative aligns with the SFDA's commitment to encouraging innovators, supporting national industries, and empowering investors regarding products under its oversight.
• In October 2024, The Krishna Institute of Medical Sciences (KIMS) has signed a memorandum of understanding (MoU) with Wipro GE Healthcare to procure medical technology and services worth up to Rs 700 crore. The MoU covers new products, replacements, and sewices for 12 KIMS hospitals and 4 upcoming hospitals over the next three years. The MoU covers a full suite of medical technology products designed by Wipro GE Healthcare.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hospital and laboratory equipment market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Investments in Healthcare Infrastructure
• 4.2. Restraints
  • 4.2.1. Stringent Regulatory Requirements
• 4.3. Opportunity
  • 4.3.1. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
  • 6.1.2. Market Attractiveness Index, By Product type
• 6.2. Hospital Equipment *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Laboratory Equipment

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Automated Equipment*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Manual Equipment
• 7.4. Semi-Automated Systems

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Diagnostic Laboratories
• 8.4. Academic and Research Institutes
• 8.5. Specialty Clinics

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Medtronic Plc*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. GE Healthcare
• 11.3. Philips Healthcare
• 11.4. Siemens Healthineers
• 11.5. Stryker Corporation
• 11.6. Hill-Rom Holdings, Inc.
• 11.7. Thermo Fisher Scientific
• 11.8. Agilent Technologies
• 11.9. PerkinElmer, Inc
• 11.10. Roche Diagnostics (LIST NOT EXHAUSTIVE)

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us